Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ACELYRIN, Inc. | 673,621 | reported | 09 May 2023 | tx 8+851,379−758,847 |
| Ultragenyx Pharmaceutical Inc. | 66,695 | reported | 14 Oct 2022 | tx 13+155,400−12,805 |
| Oric Pharmaceuticals, Inc. | 40,000 | reported | 02 Jan 2026 | tx 7+224,675 |
| Prelude Therapeutics Inc | 38,000 | reported | 12 Jun 2025 | tx 7+156,102 |
| MADRIGAL PHARMACEUTICALS, INC. | 12,610 | reported | 06 Mar 2026 | tx 37+26,065−13,730 |
| Adamas Pharmaceuticals Inc | 10,000 | reported | 02 Jun 2021 | tx 7+80,000 |
| PORTOLA PHARMACEUTICALS INC | 0 | reported | 02 Jul 2020 | tx 113+1,036,120−1,164,541 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Mar 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 160 | 434.20 USD | |
| 06 Mar 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 80 | 435.32 USD | |
| 06 Mar 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 80 | 436.69 USD | |
| 06 Mar 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 40 | 437.65 USD | |
| 04 Mar 2026 | GRANT_AWARD | MADRIGAL PHARMACEUTICALS, INC. | 5,215 | 0.00 USD | |
| 06 Mar 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 646 | 431.94 USD | |
| 06 Mar 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 40 | 425.08 USD | |
| 06 Mar 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 420 | 426.86 USD | |
| 06 Mar 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 80 | 427.85 USD | |
| 06 Mar 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 160 | 429.00 USD | |
| 06 Mar 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 40 | 429.58 USD | |
| 06 Mar 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 120 | 430.90 USD | |
| 06 Mar 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 116 | 432.56 USD | |
| 04 Mar 2026 | GRANT_AWARD | MADRIGAL PHARMACEUTICALS, INC. | 6,519 | 0.00 USD | deriv |
| 02 Mar 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 1,183 | 427.21 USD | |
| 02 Jan 2026 | GRANT_AWARD | Oric Pharmaceuticals, Inc. | 40,000 | 0.00 USD | deriv |
| 02 Dec 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 717 | 574.00 USD | |
| 02 Dec 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 80 | 596.19 USD | |
| 02 Dec 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 74 | 595.20 USD | |
| 02 Dec 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 160 | 590.37 USD | |
| 02 Dec 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 160 | 589.65 USD | |
| 02 Dec 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 240 | 587.85 USD | |
| 02 Dec 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 240 | 585.44 USD | |
| 02 Dec 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 480 | 579.85 USD | |
| 02 Dec 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 258 | 578.83 USD |
1 purchase reported after at least 12 months of silence — most recent on 09 May 2023.